How we used a hybrid qual-quant methodology to assess the market opportunity for a new rare disease treatment
Our client is a recently established independent biopharmaceutical company specialising in small molecule development. They were developing a new oral compound for the treatment of a rare genetic disease for which the standard treatment is administered intravenously, however a large proportion of patients receive monitoring only or remain undiagnosed. Their objective was to successfully launch their product in order to provide clinically meaningful benefits to patients and contribute to the overall growth of their business.
Research Partnership welcomes Misti Paul as Analytics Director
Research Partnership is pleased to welcome Misti Paul, who recently joined the company as Analytics Director.
Misti has over 16 years’ experience in statistical modeling and market research. Before joining Research Partnership, Misti headed up her own advanced statistical consultancy firm Advanced Analytics, providing statistical modeling and consulting services to global pharmaceutical, biotech and medical device companies. She specialised in the areas of merger and acquisition modelling, segmentation, new product development, conjoint methodologies and other analytical techniques.
Comparing apples and oranges: Is a global segmentation transferable?
When our clients are considering primary market research in emerging markets they typically face two challenges - a lack of good local data and budget.
The absence of reliable and up-to-date information in emerging markets should mean that a greater budget is allocated to primary market research. However, in reality the opposite is true. Consequently, our clients want to know if they can tailor global studies to reflect the nuances of different emerging markets.
A researcher’s guide to Key Driver Analysis
Research Manager Kayleigh Simpson explores how Key Driver Analysis can be used to answer key business questions
During my time as a healthcare market researcher I’ve learned that there are three key business questions that are critical to marketing success - Which product features drive the prescribing of a product? Which are the most important factors that influence likelihood to use a product that’s soon to be launched? Finally, what factors drive brand satisfaction and consumer loyalty? If you can confidently answer these questions then you’re on the road to success. The good news – there’s an analytical process that answers all these questions.
How facial analysis was used to evaluate the emotional impact of a disease promotion campaign
Our client had developed a visual and emotion-invoking, online disease awareness campaign aimed at challenging physicians’ current perceptions of treatment. Research was required to understand physicians’ reactions to the campaign (rational and emotional) and whether it would have the desired effect of increasing use of their treatment in the future, to help encourage the client’s local operating companies to adopt and roll out the campaign.